The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...

Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader who's worried about using petroleum jelly.

Weight loss that resulted from the drug was probably ... nine people who took GLP-1 antidiabetic drugs, including semaglutide. The review featured four semaglutide patients who developed ...

In the face of abrupt weight loss, one of the most common consequences is hair loss, even after bariatric surgery. Losing ...

RANI READ THE FULL RANI RESEARCH REPORT On February 5 th , Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...